The present invention refers to a process for a catalytic aryl transfer to rearrange the backbone of aromatic C—X bonds.

The present invention refers to a process for a catalytic aryl transfer to rearrange the backbone of aromatic C—X bonds.

The present invention relates to 4-substituted phenylamidine derivatives of the general formula (I), wherein R5-R6, ArA4, D, G, B, Q and an integer m have the meanings as defined in the description. The invention further relates to methods for their preparation and use of said compounds for controlling undesired phytopathogenic microorganisms, and agents for said purpose, comprising said phenylamine derivatives. This invention further relates to a method for controlling undesired phytopathogenic microorganisms by application of said 4-substituted phenylamidine derivatives of general formula (I) to such undesired microorganisms and/or to their habitat, according to the invention.

The present disclosure relates to compounds and methods of killing or inhibiting the growth of bacteria by disrupting chaperonin-mediated refolding of proteins.

The present disclosure relates to compounds and methods of killing or inhibiting the growth of bacteria by disrupting chaperonin-mediated refolding of proteins.

Compounds of formula (I), wherein R.sub.1 is as defined in the claims, exhibit COMT enzyme inhibiting activity and are thus useful as COMT inhibitors. Methods of treatment and pharmaceutical dosage forms are also disclosed.

Compounds of formula (I), wherein R.sub.1 is as defined in the claims, exhibit COMT enzyme inhibiting activity and are thus useful as COMT inhibitors. Methods of treatment and pharmaceutical dosage forms are also disclosed.

Provided is a compound represented by formula (1):

##STR00001##

In the formula, A represents a polymerizable group; L represents an optionally branched (n+1)-valent linking group; R.sup.1 represents an aromatic ring group optionally having a substituent; R.sup.2 represents a monovalent organic group optionally having a substituent; X.sup.1 and X.sup.2 each independently represent an oxygen atom, a sulfur atom, or a nitrogen atom optionally having a substituent; m represents an integer of 0 or 1; n represents an integer of 1 to 3; and p represents an integer of 0 or 1. The two R.sup.1s may be bonded together at any position to form a ring structure and R.sup.1=R.sup.2, X.sup.1=X.sup.2, and p=1 do not hold simultaneously. The compound simultaneously has a high refractive index and high transparency.

Provided is a compound represented by formula (1):

##STR00001##

In the formula, A represents a polymerizable group; L represents an optionally branched (n+1)-valent linking group; R.sup.1 represents an aromatic ring group optionally having a substituent; R.sup.2 represents a monovalent organic group optionally having a substituent; X.sup.1 and X.sup.2 each independently represent an oxygen atom, a sulfur atom, or a nitrogen atom optionally having a substituent; m represents an integer of 0 or 1; n represents an integer of 1 to 3; and p represents an integer of 0 or 1. The two R.sup.1s may be bonded together at any position to form a ring structure and R.sup.1=R.sup.2, X.sup.1=X.sup.2, and p=1 do not hold simultaneously. The compound simultaneously has a high refractive index and high transparency.

Compounds of formula (I), wherein R.sub.1 is as defined in the claims, exhibit COMT enzyme inhibiting activity and are thus useful as COMT inhibitors. Methods of treatment and pharmaceutical dosage forms are also disclosed.